Rigel Pharmaceuticals RIGL
$ 27.46
0.88%
Quarterly report 2024-Q3
added 11-07-2024
Rigel Pharmaceuticals EV/EBITDA Ratio 2011-2024 | RIGL
Annual EV/EBITDA Ratio Rigel Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-28.4 | -21.4 | -5.54 | -3.77 | -5.88 | -2.84 | -3.97 | -1.87 | -2.98 | -4.6 | -7.06 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-1.87 | -28.4 | -8.03 |